Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2680009 | 0.87 | CYP1A2 (0.33) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL11568620 | 0.87 | TSHR (0.35) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL15741151 | 0.83 | NPC1 (0.35) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL11294608 | 0.82 | CYP1A2 (0.33) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL11496194 | 0.80 | RAB9A (0.36) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL2291480 | 0.79 | ALDH1A1 (0.40) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4147317 | 0.79 | APEX1 (0.36) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL21248551 | 0.75 | CA2 (0.48) | TSHRCYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL3031172 | 0.75 | ALDH1A1 (0.38) | ALDH1A1NPC1PLA2G1BNFKB1CASP3 | |
| SCHEMBL3107810 | 0.75 | ROCK2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054698-A1 | Granular Polymer Additives and Their Preparation | ALBEMARLE CORPORATION (US) | 2009-02-26 | — | — | US | disclosed |
| US-7425290-B2 | Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying | ALBEMARLE CORPORATION (US) | 2008-09-16 | — | — | US | disclosed |
| US-20050009725-A1 | Compaction; dry granulation; uniform mixture; steric hindrance phenolic compound and polymer; forming paste; compression, shaping; drying | ALBEMARLE CORPORATION | 2005-01-13 | — | — | US | disclosed |
| US-6821456-B2 | STERICALLY-HINDERED PHENOLIC COMPOUND MIXTURE; INTERBONDS IN SITU WITH DESOLVATED SURFACES | ALBEMARLE CORPORATION | 2004-11-23 | — | — | US | disclosed |
| EP-1383833-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2004-01-28 | — | — | EP | disclosed |
| EP-1363972-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2003-11-26 | — | — | EP | disclosed |
| US-20030193041-A1 | Sterically-hindered phenolic compound mixture; interbonds in situ with desolvated surfaces | ALBEMARLE CORPORATION | 2003-10-16 | — | — | US | disclosed |
| US-6515052-B2 | Granular polymer additives and their preparation | ALBEMARLE CORPORATION | 2003-02-04 | — | — | US | disclosed |
| WO-2002068523-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2002-09-06 | — | — | WO | disclosed |
| WO-2002068524-A1 | GRANULAR POLYMER ADDITIVES AND THEIR PREPARATION | ALBEMARLE CORPORATION (US) | 2002-09-06 | — | — | WO | disclosed |
| US-20020117651-A1 | Granular polymer additives and their preparation | ALBEMARLE CORPORATION | 2002-08-29 | — | — | US | disclosed |
| EP-0004026-B1 | HYDROLYTICALLY STABLE ORTHO-ALKYLATED PHENYL PHOSPHONITES AND STABILIZED COMPOSITIONS | CIBA-GEIGY AG (CH) | 1982-05-05 | — | — | EP | disclosed |
| EP-0004026-A1 | Hydrolytically stable ortho-alkylated phenyl phosphonites and stabilized compositions | CIBA-GEIGY AG (CH) | 1979-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054698-A1 | Granular Polymer Additives and Their Preparation | GRN, C9, COG4 | TSHR 4509/4885CYP1A2 2404/4885CYP3A4 1939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.